Andrea Riposati CEO and Mattia Capulli CSODante Genomics, a leading global genomics and precision medicine company, aims to bridge this inaccessibility gap and make WGS accessible to everyone. The company leverages WGS technology and variant interpretation to help consumers and healthcare specialists make informed decisions about their/patient’s health.
“We make whole genome sequencing tests accessible and affordable to everyone,” says Francesco Pennelli, senior director of marketing, Dante Genomics.
Dante Genomics has numerous sequencing centers worldwide in Europe, the U.S., and the United Arab Emirates that use highly advanced genomics software, Avanti, to interpret the data from genome sequencing tests. The intuitive web-based DNA raw data analysis platform can analyze hundreds of gigabytes of genomic data and transform it into insightful and actionable reports within minutes. Avanti generates more than 100 reports daily, from clinical panels to nutrition and fitness reporting.
Avanti’s pricing model is also straightforward. Practitioners can pay per analysis without any upfront costs, subscriptions, or cancellation fees.
Individuals who wish to have their genome sequenced to make better health decisions can purchase tests online with no shipping cost. They can collect their blood sample in an easy, painless, and aseptic way with Dante Genomics’ straightforward explanatory video. Once it receives samples, the company provides individuals with easily comprehensible reports within a few weeks, which are accessible to them throughout their life. In other words, customers sequence their genomes once in their life and have genomic data available at any time.
We make whole genome sequencing tests accessible and affordable to everyone
The genomic data by Dante Genomics provides doctors with a unique tool and the information to treat and prevent some deadly diseases in the best way possible. The company continually makes efforts to engage more people and spread awareness about the benefits of genome sequencing tests. Dante Genomics believes genome sequencing tests will be the gold standard within the genomic industry in the coming years and continues to work toward making WGS technology accessible to all.


